CannAssist (OTCQB: CNSC), owner of Xceptor Labs, is a biotechnological pharmaceutical and wellness company. Established in May 2017, CannAssist is headquartered in San Diego County, California, and markets its consumer line of cannabidiol (“CBD”) products under the Xceptol brand. A recent article discussing the company reads, “Xceptor Labs’ technology, CiBiDinol, is formulated using a proprietary process developed by CNSC founder Mark Palumbo. It is specifically designed to address many critical issues with oil-soluble CBD molecules, including delivery, bioavailability and short shelf-life. This technology provides the basis for Xceptor Labs and Xceptol consumer products.”
To view the full article, visit https://ibn.fm/Q250b
About CannAssist International Corporation
CannAssist produces and sells its cannabidiol (“CBD”) product, “CiBiDinol,” which is formulated based on a proprietary process developed by its founder Mark Palumbo. CBD is a non-psychoactive compound found in hemp. CannAssist’s research and development work dramatically enhanced the bioavailability of desired molecular structures, resulting in the creation of a line of CBD products, most notably its CBD product, CiBiDinol. CiBiDinol is available as a raw material and is also the foundation of CannAssist’s line of consumer products under its Xceptol brand available as topicals and ingestibles at www.Xceptol.com. For more information, visit the company’s website at www.CannAssistInternational.com.
NOTE TO INVESTORS: The latest news and updates relating to CNSC are available in the company’s newsroom at https://ibn.fm/CNSC
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.investorwire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]
InvestorWire is part of the InvestorBrandNetwork.